SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Panacea Biotec to supply Pentavalent Vaccine Easyfive-TT to UNICEF

14 Feb 2014 Evaluate

Panacea Biotec, one of the leading research based health management companies of India, has received UNICEF award for supply of the company’s DTP-HepB-Hib (Pentavalent) Vaccine Easyfive-TT to UNICEF during the period 2014-2016. This award to the company is the outcome of the recent relisting of the its Pentavalent Vaccine by World Health Organisation (WHO) on October 02, 2013, post successful completion of the audit of the company’s Lalru and Baddi facilities conducted by WHO team from February 28 until March 01, 2013.

UNICEF is yet to award a part of the total forecast quantities for the above said period and the un-awarded quantities (including any potential additional requirement for India) will be awarded at a later stage in line with the demand forecast at such time. The suppliers performance across all vaccines supplied to UNICEF will also be taken into account when additional incremental awards are determined. The company has also started supplying Easyfive-TT to international markets against UNICEF purchase orders.

Panacea Biotec is one of India’s leading research based health management companies with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

358.00 5.30 (1.50%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×